Sponsors to benefit from simplified home-based clinical trials: LabConnect CEO

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Kwanchai_Khammuean)
(Image: Getty/Kwanchai_Khammuean)
LabConnect and Symphony Clinical Research are teaming up to improve the delivery of home-based clinical trials by co-developing new processes and tools.

LabConnect, LLC​ provides central laboratory and support services for biopharmaceutical, medical device and, contract research organizations (CROs). The company has worked with Symphony Clinical Research, an in-home clinical service provider, on 17 studies over 12 years.

This week, the companies announced a new strategic collaboration that will focus on integrating their services to support the clinical research industry, specifically to advance home-based clinical trials.

“We both have a strategic focus on managing highly complex studies, so it’s a natural fit,”​ said Eric Hayashi, president and CEO. “Sponsors benefit from the simplicity we bring to managing complex home or alternate-site-based clinical trials.”

Hayashi told us the goal of the strategic alliance is “to jointly improve the delivery of home-based clinical trials to all stakeholders, including sponsors, sites, home health care practitioners and investigative sites.”

The companies look to accomplish this by developing new processes and tools, including a clinical kit “optimized”​ for home health nurses, reporting processes “designed with home visits in mind” ​and clinical collection kits for inbound and outbound shipping, said Hayashi.

Together, the companies will provide laboratory testing, peripheral blood mononuclear cell (PBMC) processing, reporting, and logistical services – and develop informational materials to educate clients on the process.

“There are a lot of questions regarding how this process will work,”​ Hayashi said. “We plan to work collaboratively to provide information on how clients may improve their clinical trial conduct through home-based visits.”

Related news

Show more

Related products

show more

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Discover Fermion’s new API unit 4 in Hanko

Discover Fermion’s new API unit 4 in Hanko

Recorded the 04-Sep-2018 | Webinar

Join this webinar to learn more about Fermion’s new manufacturing unit 4 at the Hanko site. This webinar will provide virtual tour to our new state of...

Related suppliers

Follow us

Featured Events

View more


View more